Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12611000357954
Ethics application status
Not yet submitted
Date submitted
4/04/2011
Date registered
6/04/2011
Date last updated
6/04/2011
Type of registration
Prospectively registered
Titles & IDs
Public title
Tyrosine supplementation in preventing the cognitive effects of psychosocial stress
Query!
Scientific title
Tyrosine supplementation versus placebo in preventing the cognitive effects of psychosocial stress in healthy adults
Query!
Secondary ID [1]
259917
0
Nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Stress
265524
0
Query!
Condition category
Condition code
Mental Health
265681
265681
0
0
Query!
Studies of normal psychology, cognitive function and behaviour
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Once off administration of an oral solution containing either the natural amino acid tyrosine (at a dose of either 100mg/kg or 200mg/kg) or a placebo to healthy adult (male and female) volunteers, two hours prior to exposure to psychosocial stressor (Trier Social Stress Test). To be administered randomly and in a blinded manner
Query!
Intervention code [1]
264340
0
Treatment: Drugs
Query!
Intervention code [2]
264351
0
Prevention
Query!
Comparator / control treatment
Placebo (i.e. oral glucose solution)
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
266458
0
Change in neurocognition as measured by neurocogntive tests battery including simple and choice reaction time, verbal episodic memory, groton maze learning task
Query!
Assessment method [1]
266458
0
Query!
Timepoint [1]
266458
0
To be measured during one day of testing - at baseline, immediately following administration of Trier Social Stress Test and again one hour later
Query!
Secondary outcome [1]
273813
0
Change in biochemical markers of stress (salivary cortisol and alpha-amylase) and central dopamine activity (serum prolactin)
Query!
Assessment method [1]
273813
0
Query!
Timepoint [1]
273813
0
To be measured during one day of testing - at baseline, immediately pre- and post-administration of Trier Social Stress Test and again one hour later
Query!
Eligibility
Key inclusion criteria
Healthy adult volunteers
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
45
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Past or present mental illness
Family history of mental illness
Any medication or illicit substance use
Pregnant
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation concealed through the use of an "off-site" allocation schedule. The holder of the schedule contacted following enrollment of a subject
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation by using a randomisation table created by a computer
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/05/2011
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
60
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
264803
0
Government body
Query!
Name [1]
264803
0
National Health and Medical Research Council
Query!
Address [1]
264803
0
Level 1
16 Marcus Clarke Street
Canberra ACT 2601
Query!
Country [1]
264803
0
Australia
Query!
Primary sponsor type
Individual
Query!
Name
Dr Lanny Bochsler
Query!
Address
Department of Psychiatry
University of Melbourne
Austin Health
145 Studley Rd
Heidelberg Victoria 3084
Query!
Country
Australia
Query!
Secondary sponsor category [1]
263915
0
None
Query!
Name [1]
263915
0
Query!
Address [1]
263915
0
Query!
Country [1]
263915
0
Query!
Other collaborator category [1]
251926
0
Individual
Query!
Name [1]
251926
0
Associate Professor James Olver
Query!
Address [1]
251926
0
Department of Psychiatry
University of Melbourne
Austin Health
145 Studley Rd
Heidelberg Victoria 3084
Query!
Country [1]
251926
0
Australia
Query!
Other collaborator category [2]
251927
0
Individual
Query!
Name [2]
251927
0
Associate Professor Trevor Norman
Query!
Address [2]
251927
0
Department of Psychiatry
University of Melbourne
Austin Health
145 Studley Rd
Heidelberg Victoria 3084
Query!
Country [2]
251927
0
Australia
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
266780
0
Austin Health Human Research Ethics Committee
Query!
Ethics committee address [1]
266780
0
Austin Health 145 Studley Rd Heidelberg Victoria 3084
Query!
Ethics committee country [1]
266780
0
Australia
Query!
Date submitted for ethics approval [1]
266780
0
16/03/2011
Query!
Approval date [1]
266780
0
Query!
Ethics approval number [1]
266780
0
EC00204
Query!
Summary
Brief summary
This study aims to evaluate the effects of the administration of the natural amino acid, tyrosine, compared with that of a placebo on the cognitive functioning of healthy adult volunteers subjected to an acute psychosocial stress event. This is based on the hypothesis that pre-test administration with tyrosine will prevent or reduce the negative impact of psychosocial stress on a broad range of cognitive tasks through its effect on neurotransmitter functioning
Query!
Trial website
Nil
Query!
Trial related presentations / publications
Nil
Query!
Public notes
Query!
Contacts
Principal investigator
Name
32438
0
Query!
Address
32438
0
Query!
Country
32438
0
Query!
Phone
32438
0
Query!
Fax
32438
0
Query!
Email
32438
0
Query!
Contact person for public queries
Name
15685
0
Ann Pisarevsky
Query!
Address
15685
0
Department of Psychiatry
University of Melbourne
Austin Health
145 Studley Rd
Heidelberg Victoria 3084
Query!
Country
15685
0
Australia
Query!
Phone
15685
0
+61 3 94965000
Query!
Fax
15685
0
Query!
Email
15685
0
[email protected]
Query!
Contact person for scientific queries
Name
6613
0
Dr Lanny Bochsler
Query!
Address
6613
0
Department of Psychiatry
University of Melbourne
Austin Health
145 Studley Rd
Heidelberg Victoria 3084
Query!
Country
6613
0
Australia
Query!
Phone
6613
0
+61 3 94965000
Query!
Fax
6613
0
Query!
Email
6613
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF